Literature DB >> 26265812

A rare case of leukemic presentation of blastoid variant of mantle cell lymphoma with isolated splenic involvement: Flowcytometric revelation.

Jyoti Kotwal1, Ajay Malik2, Vibha Dutta3, Vikram Singh4, Sandeep Kumar Dahiya5, Velu Nair6, Rajan Kapoor7.   

Abstract

Entities:  

Keywords:  Blastoid mantle cell lymphoma; Flowcytometry; Leukemic presentation

Year:  2013        PMID： 26265812      PMCID： PMC4529545          DOI： 10.1016/j.mjafi.2013.09.014

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  8 in total

1.  Mantle cell lymphoma, blastoid variant presenting as acute leukemia - a rare case report.

Authors:  S Singh
Journal:  Indian J Cancer       Date:  2011 Jul-Sep       Impact factor: 1.224

Review 2.  Biology and therapy of mantle cell lymphoma.

Authors:  Michael E Williams; John J Densmore
Journal:  Curr Opin Oncol       Date:  2005-09       Impact factor: 3.645

3.  Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma.

Authors:  Hiroyuki Tagawa; Miyuki Suguro; Shinobu Tsuzuki; Keitaro Matsuo; Sivasundaram Karnan; Koichi Ohshima; Masataka Okamoto; Yasuo Morishima; Shigeo Nakamura; Masao Seto
Journal:  Blood       Date:  2005-05-10       Impact factor: 22.113

4.  Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders.

Authors:  K F Wong; J K Chan; J C So; P H Yu
Journal:  Cancer       Date:  1999-09-01       Impact factor: 6.860

5.  Leukemic mantle cell lymphoma: clinical and pathologic spectrum of twenty-three cases.

Authors:  E Schlette; R Lai; M Onciu; D Doherty; C Bueso-Ramos; L J Medeiros
Journal:  Mod Pathol       Date:  2001-11       Impact factor: 7.842

6.  Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.

Authors:  J Z Gong; A S Lagoo; D Peters; J Horvatinovich; P Benz; P J Buckley
Journal:  Am J Clin Pathol       Date:  2001-12       Impact factor: 2.493

Review 7.  Prolymphocytic leukemias.

Authors:  Biju Krishnan; Estella Matutes; Claire Dearden
Journal:  Semin Oncol       Date:  2006-04       Impact factor: 4.929

8.  Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma.

Authors:  Hannes Kaufmann; Markus Raderer; Stefan Wöhrer; Andreas Püspök; Alexander Bankier; Christoph Zielinski; Andreas Chott; Johannes Drach
Journal:  Blood       Date:  2004-05-27       Impact factor: 22.113
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.